Mather Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Mather Group's RMD Position: Q3 2026 in Review
Mather Group reduced its ResMed (RMD) stake by 1.2% in Q3 2026, selling an estimated $1.74K and leaving 636 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #875.
Mather Group first reported a position in RMD in Q2 2022 and has held it in 14 quarters since. The position peaked at $339K in Q3 2022. 167 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Mather Group held 636 shares of ResMed worth $141K as of Q3 2026.
- Mather Group sold 8 ResMed shares in Q3 2026, an estimated $1.74K.
- ResMed made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #875 holding.
- Mather Group first reported a position in ResMed in Q2 2022 and has held it in 14 quarters since.
- Mather Group's ResMed position peaked at $339K in Q3 2022.
- 167 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.